MDMA was hyped as a promising treatment for PTSD – what went wrong?



MDMA has long been used recreationally but it has faced obstacles getting approved for medical therapies
Shutterstock / Couperfield
“The future is psychedelic,” declared Rick Doblin, founder of Lykos Therapeutics, at a conference on psychedelic drugs last year. Several studies, many of them funded by Lykos, had provided tantalising signs that pairing MDMA with talk therapy could dramatically reduce symptoms of post-traumatic stress disorder (PTSD). As a result, Doblin was one of many advocates touting the drug as key to revolutionising mental healthcare.
But just a year later,…
You Might Also Like
Any wall can be turned into a camera to see around corners
Technology for seeing around corners would be of use to the militaryMatthew Horwood/Getty Images An ordinary camera could soon take...
We’re about to unlock the secrets of ancient human brains
Brains preserved for hundreds of years can contain intact proteinsAlexandra Morton-Hayward It is now possible to obtain proteins from preserved...
Trump’s Golden Dome defence project could spur a space arms race
US President Donald Trump (left), accompanied by US Secretary of Defense Pete Hegseth (right), announces the Golden Dome missile defense...
New dwarf planet spotted at the edge of the solar system
The orbits of a potential dwarf planet called 2017 OF201 and the dwarf planet SednaTony Dunn A potential dwarf planet...